Miltefosine for Mucosal Leishmaniasis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-04-30

Study Completion Date

2006-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial will study miltefosine as a treatment for mucosal leishmaniasis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Treat bolivian mucosal leishmaniasis with miltefosine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leishmaniasis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

mucosal leishmaniasis miltefosine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

miltefosine 2.5 mg/kg/day for 28 days

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mucosal leishmaniasis

Exclusion Criteria

* Abnormal liver function tests (LFT)
* Abnormal kidney function test
* Concomitant diseases

Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaime soto, MD

Role: PRINCIPAL_INVESTIGATOR

CIBIC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Palos Blancos, , Bolivia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bolivia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

04--01

Identifier Type: -

Identifier Source: org_study_id